None
Quote | TScan Therapeutics Inc. (NYSE:TCRX)
Last: | $ |
---|---|
Change Percent: | 0.08% |
Open: | $25.06 |
Close: | $25.09 |
High: | $25.0981 |
Low: | $25.06 |
Volume: | 3,275 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | TScan Therapeutics Inc. (NYSE:TCRX)
2024-06-26 16:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Garry A. Nicholson, an experienced executive with regulatory and commercial expertise, joins the Board of Directors Timothy Barberich retires as Chair; Stephen Biggar, M.D., Ph.D. assumes the role of Chair WALTHAM, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. ...
Message Board Posts | TScan Therapeutics Inc. (NYSE:TCRX)
Subject | By | Source | When |
---|---|---|---|
Quote, they have presentation on 17th, | crazy horse 0 | investorshub | 05/10/2023 5:08:44 PM |
Also another huge catalyst is waiting on, once | dinogreeves | investorshub | 05/10/2023 4:02:47 PM |
As of yesterday it was higher than 23%, | dinogreeves | investorshub | 05/10/2023 3:51:50 PM |
5% shorted ? Where will it squeeze. | IOUBLOKE1 | investorshub | 05/10/2023 3:43:12 PM |
Crazy Horse, brother, I have been watching the | dinogreeves | investorshub | 05/10/2023 3:31:20 PM |
News, Short Squeeze, Breakout and More Instantly...
TScan Therapeutics Inc. Company Name:
TCRX Stock Symbol:
NYSE Market:
2024-06-26 16:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Garry A. Nicholson, an experienced executive with regulatory and commercial expertise, joins the Board of Directors Timothy Barberich retires as Chair; Stephen Biggar, M.D., Ph.D. assumes the role of Chair WALTHAM, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. ...
WALTHAM, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced that the Com...